Characterising novel therapeutic targets for neuroblastoma

Our objective

The Olivia Hodson Cancer Fund’s objective is to provide, “Support for research and clinical advancements within the departments of Oncology, Haematology and Bone Marrow Transplant at Great Ormond Street Hospital”.

Characterising novel therapeutic targets for neuroblastoma

OHCF is supporting significant research into potential new therapies for this very serious form of childhood cancer.

Neuroblastoma is a very serious disease for many children in the UK, accounting for 15% of paediatric cancer deaths. Current treatments have not improved long term survival for over half of advanced cases, and only two thirds of patients overall live until their fifth birthday.

One particular clinical need in the treatment of this type of cancer is for improvements in managing any residual disease and preventing relapse. A team at the Institute of Child Health is focussing their research on the effects of novel chemical combinations, with the aim of providing leads for more effective treatments to eradicate residual cancer cells.

Whilst this project already receives some funding, a donation by OHCF will facilitate deeper and more significant research and enable the team to complete all of their intended objectives.